Identifying and measuring the severity of somatic symptom disorder using the Self-reported Somatic Symptom Scale-China (SSS-CN): a research protocol for a diagnostic study

Meng Jiang, Weituo Zhang, Xuan Su, Chuang Gao, Bingxu Chen, Zehao Feng, Jialiang Mao, Jun Pu, Meng Jiang, Weituo Zhang, Xuan Su, Chuang Gao, Bingxu Chen, Zehao Feng, Jialiang Mao, Jun Pu

Abstract

Introduction: The detection rate of somatic symptom disorder (SSD) in general hospitals is unsatisfactory. Self-report questionnaires that assess both somatic symptoms and psychological characteristics will improve the process of screening for SSD. The Somatic Symptom Scale-China (SSS-CN) questionnaire has been developed to meet this urgent clinical demand. The aim of this research is to validate the self-reported SSS-CN as a timely and practical instrument that can be used to identify SSD and to assess the severity of this disorder.

Methods and analysis: At least 852 patients without organic disease but presenting physical discomfort will be recruited at a general hospital. Each patient will undergo a Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5)-guided physician diagnosis, including disease identification and severity assessment, as the reference standard. This research will compare the diagnostic performance of the SSS-CN for SSD, the Patient Health Questionnaire-15 (PHQ-15) and other SSD-related questionnaires. Statistical tests to measure the area under the curve (AUC) and volume under the surface of the receiver operating curve will be used to assess the accuracy of the SSD identification and the severity assessment, respectively. In addition to this standard diagnostic study, we will conduct follow-up investigations to explore the effectiveness of the SSS-CN in monitoring treatment effects.

Ethics and dissemination: Ethical approval was obtained from the Renji Hospital Human Research Ethics Committee, approval number 2 015 016. The findings of this study will be disseminated via peer-reviewed journals and presented at international conferences.

Trial registration number: NCT03513185.

Keywords: mental disorders management; somatic symptom disorder; somatic symptom scale-china.

Conflict of interest statement

Competing interests: None declared.

© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Figures

Figure 1
Figure 1
The Somatic Symptom Scale-China.
Figure 2
Figure 2
Study flow. GAD-7, Generalised Anxiety Disorder Scale-7; PHQ-9, Patient Health Questionnaire-9; PHQ-15, Patient Health Questionnaire-15; SF-20, 20-item Short Form Health Survey; SSD, somatic symptom disorder; SSS-CN, somatic symptom scale-China.

References

    1. Barsky AJ, Orav EJ, Bates DW. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005;62:903–10. 10.1001/archpsyc.62.8.903
    1. American Psychiatric Association Diagnostic and statistical manual of mental disorders (DSM-5. 5th edn Arlington, VA: American Psychiatric Association Publishing, 2013.
    1. Barsky AJ. Assessing somatic symptoms in clinical practice. JAMA Intern Med 2014;174:407–8. 10.1001/jamainternmed.2013.12177
    1. Liang D, Mays VM, Hwang W-C. Integrated mental health services in China: challenges and planning for the future. Health Policy Plan 2018;33:107–22. 10.1093/heapol/czx137
    1. Smith GR. The course of somatization and its effects on utilization of health care resources. Psychosomatics 1994;35:263–7. 10.1016/S0033-3182(94)71774-6
    1. Hahn SR, Kroenke K, Spitzer RL, et al. . The difficult patient: prevalence, psychopathology, and functional impairment. J Gen Intern Med 1996;11:1 10.1007/bf02603477
    1. Axelsson E, Andersson E, Ljótsson B, et al. . The health preoccupation diagnostic interview: inter-rater reliability of a structured interview for diagnostic assessment of DSM-5 somatic symptom disorder and illness anxiety disorder. Cogn Behav Ther 2016;45:259–69. 10.1080/16506073.2016.1161663
    1. Leong FT, Lau AS. Barriers to providing effective mental health services to Asian Americans. Ment Health Serv Res 2001;3:201–14. 10.1023/A:1013177014788
    1. Gierk B, Kohlmann S, Kroenke K, et al. . The somatic symptom scale-8 (SSS-8): a brief measure of somatic symptom burden. JAMA Intern Med 2014;174:399–407. 10.1001/jamainternmed.2013.12179
    1. Gierk B, Kohlmann S, Toussaint A, et al. . Assessing somatic symptom burden: a psychometric comparison of the patient health questionnaire-15 (PHQ-15) and the somatic symptom scale-8 (SSS-8). J Psychosom Res 2015;78:352–5. 10.1016/j.jpsychores.2014.11.006
    1. Tu C-Y, Liao S-C, Liu C-Y, et al. . Application of the Chinese version of the Whiteley Index-7 for detecting DSM-5 somatic symptom and related disorders. Psychosomatics 2016;57:283–91. 10.1016/j.psym.2015.12.010
    1. Toussaint A, Murray AM, Voigt K, et al. . Development and validation of the somatic symptom Disorder-B criteria scale (SSD-12). Psychosom Med 2016;78:5–12. 10.1097/PSY.0000000000000240
    1. Toussaint A, Löwe B, Brähler E, et al. . The Somatic Symptom Disorder - B Criteria Scale (SSD-12): Factorial structure, validity and population-based norms. J Psychosom Res 2017;97:9–17. 10.1016/j.jpsychores.2017.03.017
    1. Laferton JAC, Stenzel NM, Rief W, et al. . Screening for DSM-5 somatic symptom disorder: diagnostic accuracy of self-report measures within a population sample. Psychosom Med 2017;79:974–81. 10.1097/PSY.0000000000000530
    1. European Medicines Agency, Pre-authorisation evaluation of medicines for human use . Guideline on clinical evaluation of diagnostic agents. Available:
    1. Qi Z, Jialiang M, Chunbo L, et al. . Developing of somatic self-rating scale and its reliability and validity. Chinese Journal of Behavioral Medicine and Brain Science 2010;19:847–9.
    1. Nakas CT, Yiannoutsos CT. Ordered multiple-class ROC analysis with continuous measurements. Stat Med 2004;23:3437–49. 10.1002/sim.1917
    1. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837–45. 10.2307/2531595
    1. Shen Y-C, Zhang M-Y, Huang Y-Q, et al. . Twelve-month prevalence, severity, and unmet need for treatment of mental disorders in metropolitan China. Psychol Med 2006;36:257–67. 10.1017/S0033291705006367
    1. Phillips MR, Zhang J, Shi Q, et al. . Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet 2009;373:2041–53. 10.1016/S0140-6736(09)60660-7
    1. Liu C, Chen L, Xie B, et al. . Number and characteristics of medical professionals working in Chinese mental health facilities. Shanghai Arch Psychiatry 2013;25:277–85. 10.3969/j.issn.1002-0829.2013.05.003
    1. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. primary care evaluation of mental disorders. patient health questionnaire. JAMA 1999;282:1737–44. 10.1001/jama.282.18.1737

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner